Australian Pharmaceutical Industries Archives - Inside FMCG
API reports $4.0 billion in revenue for FY19 as flagship health and beauty retailer sees like-for-like sales return to growth.
CEO Richard Vincent said API is no rush to sell its Sigma shares.
Drug distributor plans to buy its rival in the face of increased competitive and regulatory pressures.
In the headlines this week.
The group will soon have 462 stores.
Australian Pharmaceutical Industries expects to lift underlying profit despite a tough retail environment.